FEATURES OF THE CLINICAL COURSE AND DIAGNOSIS OF EARLY RHEUMATOID ARTHRITIS

Authors

  • Tashpulatova M.M.

Keywords:

early rheumatoid arthritis, articular syndrome, clinical features, diagnostics, anticyclic citrulline peptide,14-3-3η protein

Abstract

Purpose of the research was studying of clinical features and diagnostic significance of 14-3-3η protein in the blood of patients at the early stages of disease.

References

American Intercollegiate of rheumatologists. Recommendations for use of basic anti-inflammation preperations and Biologic agents in rheumatoid arthritis. // Clinical pharmacology and therapy.- 2018.- Vol. 18, N 1. - Р. 43

Bas S., Genevay S., Meyer O. Anti-cyclic citrullinated peptide antibodies in the diagnosis and prognosis of rheumatoid arthritis. // Rheumatology.-2003.-Vol.42.-P. 677-680.

Bijlsma J.W., Wcinblatt M.E. //Optimal use of the methotrexate: the advantages of tight control. Ann Reum Dis. 2017. Р.11.

Calguneri M., Pay S., Caliskaner Z. Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis. // Clin. exp. rheumatol.- 2019. Vol. 17. - Р. 699-704.

Cohen S.B., Emery P.А., Greenwald M.W., Dougados M.К., Furie R.A., Genovese M.C., Keystone E.C., Loveless J.E., Burmester G.R., Cravets M.W., Hessey E.W., Shaw T.Т., Totoritis M.C.; Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double–blind, placebo–controlled, phase III trial evaluating primary efficacy and safety at twenty four weeks. // Arthritis rheum.- 2016.- Vol. 9, N 54.- Р. 2793–2806.

Duer-Jensenс A.Н., Stewart N.О., Crabbe J.N. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. //Ann. Rheum. Dis.- 2016.Vol.6, N 7.-Р.-350. 7. Emery P., Breedveld F. C., Dougados M. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. // Ann. rheum. dis. – 2014. – Vol. 61, N 4. – P. 290–297.

Tashpulatova M.M., Nabiyeva D.A., Djuraeva E.R., Sagatova D.R., Askarov N.L. 14-3-3 (eta) protein as a new biomarker in rheumatoid arthritis// International Journal ofAdvanced Science and Technology Vol.29.-№ 5(2020). P. 1871-1877

Tashpulatova M.M.,Каsimovа М.B., Ziyayevа F.К., Sultonovа М.Х.,Sharipov Z.А. Enhancement of the diagnosis and treatment of early rheumatoid arthritis//International Journal of Pharmaceutical research 2020.12.02.0031-Vol 12.-Issue 1. P. 221-228

Downloads

Published

2021-04-29